CONSTELLATION PHARMCETICLS I's ticker is CNST and the CUSIP is 210373106. A total of 136 filers reported holding CONSTELLATION PHARMCETICLS I in Q1 2021. The put-call ratio across all filers is 1.43 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $2,688,000 | -53.3% | 114,932 | -42.4% | 0.01% | -53.6% |
| Q4 2020 | $5,750,000 | -73.5% | 199,665 | -81.3% | 0.03% | -74.8% |
| Q3 2020 | $21,678,000 | +5.0% | 1,069,994 | +55.8% | 0.11% | -17.8% |
| Q2 2020 | $20,636,000 | -57.0% | 686,720 | -55.0% | 0.14% | -65.4% |
| Q1 2020 | $47,993,000 | +103.4% | 1,526,975 | +204.9% | 0.39% | +214.5% |
| Q4 2019 | $23,593,000 | – | 500,817 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP, LLC | 3,034,083 | $37,259,000 | 42.17% |
| Svennilson Peter | 4,677,939 | $57,446,000 | 16.42% |
| VHCP Management II, LLC | 726,677 | $8,924,000 | 2.81% |
| Casdin Capital, LLC | 1,523,960 | $18,714,229,000 | 1.75% |
| P.A.W. CAPITAL CORP | 120,000 | $1,474,000 | 1.59% |
| Cormorant Asset Management, LP | 1,271,685 | $15,616,000 | 0.90% |
| VHCP Management III, LLC | 66,667 | $819,000 | 0.38% |
| Orbimed Advisors | 835,842 | $10,264,000 | 0.16% |
| Hillhouse Capital Management | 317,921 | $3,904,000 | 0.12% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 183,600 | $2,255,000 | 0.08% |